| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA4645963
Max Phase: Preclinical
Molecular Formula: C28H30ClN3O6S
Molecular Weight: 572.08
Molecule Type: Unknown
Associated Items:
Representations
Canonical SMILES: CC(C)(C)OC(=O)N1CCN(Cc2ccc(C3=CC(=O)C=CC3=O)cc2NS(=O)(=O)c2ccc(Cl)cc2)CC1
Standard InChI: InChI=1S/C28H30ClN3O6S/c1-28(2,3)38-27(35)32-14-12-31(13-15-32)18-20-5-4-19(24-17-22(33)8-11-26(24)34)16-25(20)30-39(36,37)23-9-6-21(29)7-10-23/h4-11,16-17,30H,12-15,18H2,1-3H3
Standard InChI Key: PQMPTOIHJKSFJJ-UHFFFAOYSA-N
Associated Targets(Human)
Histone-lysine N-methyltransferase SETD7 390 Activities
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 572.08 | Molecular Weight (Monoisotopic): 571.1544 | AlogP: 4.28 | #Rotatable Bonds: 6 |
| Polar Surface Area: 113.09 | Molecular Species: NEUTRAL | HBA: 7 | HBD: 1 |
| #RO5 Violations: 1 | HBA (Lipinski): 9 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 1 |
| CX Acidic pKa: 7.62 | CX Basic pKa: 4.04 | CX LogP: 4.47 | CX LogD: 4.30 |
| Aromatic Rings: 2 | Heavy Atoms: 39 | QED Weighted: 0.51 | Np Likeness Score: -0.94 |
References
| 1. Hou Z, Min W, Zhang R, Niu A, Li Y, Cao L, Han J, Luo C, Yang P, Ding H.. (2020) Lead discovery, chemical optimization, and biological evaluation studies of novel histone methyltransferase SET7 small-molecule inhibitors., 30 (9): [PMID:32173197] [10.1016/j.bmcl.2020.127061] |
Source
Source(1):